Everest Medicines is a New York-based biopharmaceutical company that develops and commercializes novel therapeutics for cancer and infectious diseases.
Business Model:
Revenue: $847.2k
Employees: 201-500
Address: 1266 West Nanjing Road
City: Shanghai
State: shanghai municipality
Zip: 200040
Country: CN
Everest Medicines is a New York-based biopharmaceutical company that develops and commercializes novel therapeutics for cancer and infectious diseases.
Contact Phone:
Contact Email:
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
10/9/2020
Ticker Symbol:
1952HK
IPO Price:
$7.096792507851633/share
Amount Raised:
$451M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2020 | IPO | $451M |
|
6/2020 | Series C | 10 | $310M |
RA Capital Management CBC Group Octagon Capital Partners Janchor Partners Hillhouse Capital Group Jiashan SDIC Janus Henderson Investors HBM Healthcare Investments AG Rock Springs Capital Decheng Capital Hillhouse Capital Group Janchor Partners RA Capital Management RA Capital Management CBC Group Octagon Capital Partners Janchor Partners Hillhouse Capital Group Jiashan SDIC Janus Henderson Investors HBM Healthcare Investments AG Rock Springs Capital Decheng Capital Hillhouse Capital Group Janchor Partners RA Capital Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|